Advertisment
|
|
news roundup
Medidata announced that CytomX Therapeutics, Inc. will expand its partnership to include Medidata Regulated Content Management solutions, eTMF Archive and SOP Management. With the use of the Medidata Clinical Cloud, CytomX will be able to manage all content in a single, unified platform—all while incorporating these new features.
| advertisment
Engaging Rare Disease Patients & Accelerating Clinical Development
In a series of white papers, PRA experts discuss the barriers drug developers face when positioning a new trial in the rare disease space and how to minimize these while engaging with the right patients.
 Download the White Papers |
| |
|
advertisment
 
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
| advertisment
Tomorrow's Clinical Trial, Powered by Modern EDC
See how to cut study build time in half, eliminate migrations, and remove the need for source data verification (SDV).
 See a preview and watch the full webinar here. |
|
Advertisment
|
|
|
COMPASS Pathways has contracted with Worldwide Clinical Trials as its CRO for its first-ever large-scale randomized, controlled trials, covering 400 patients with treatment-resistant depression in eight countries. The trial will begin in the first quarter of 2018 and is planned to include clinical sites in Czech Republic, Finland, Germany, the Netherlands, Norway, Portugal, Spain and the UK.
| advertisment
Insight to Drive Better Partnerships
SCORR Marketing, in partnership with Applied Clinical Trials, surveyed life science professionals to gain information about the critical relationship between sponsors and service providers. Read more insights in the CRO Industry Trends report.
 Get your copy today |
| |
|
advertisment
|
|
|
|
Bioserv SMO has partnered with Clinerion and iHealth Group to add their trial sites to Clinerion's PRS platform. The Hospital São Vicente de Paulo will be the first to be implemented, adding 540,000 new patient lives to the platform that can be accessed. With 60 ongoing studies at the hospital, this implementaion will help create a larger field of clinical research throughout Brazil and allow for more studies to progress.
The Metrics Champion Consortium's Vendor Oversight Work Group has published its first set of portfolio-level metrics in order to answer high-priority vendor performance questions that relate to achieving timeliness goals. Not only will the metrics report if milestones are achieved by certain dates, but MCC has also created four more performance metrics used to measure the timeliness of SUSAR reporting.
|
|
|
| advertisment
The Benefits of a Data-driven Approach to Feasibility
Live Webcast: Tuesday, March 20 at 11:00am EDT
 Register now |
| advertisment
The Search for an HIV Vaccine: The Past, The Present and The Promise
Live Webcast: Thursday, December 14 at 11:00am EST
 Register now |
|
Articles
Sponsors and CROs are looking into implementation of a risk-based monitoring approach to their clinical trials to achieve objectives related to enhanced data quality, better monitoring of patient safety, and creating efficiencies in overall operations.
| advertisment
The Clinical Trial of the Future is Here - Now: Understand how technology is transforming clinical development - now and in the future
Live Webcast: Wednesday, December 13 at 11:00am EST
 Register now |
Cancer vaccine-based immunotherapy may help overcome the resistance of certain tumors to immune checkpoint inhibitors, while immune checkpoint inhibitors may enhance the efficacy of cancer vaccine therapies.
| advertisment
Beyond #Buzzwords: How to deploy wearables and remote devices to transform your clinical trial execution
On Demand
 Learn more |
|
|
Blog Posts
In this article, Moe Alsumidaie presents an introspective method that can help clarify situational analysis and resolution of clinical trial issues.
| advertisment
Examining Trends in Biosimilar Development: A Year in Review An Open Discussion of Critical Events and Biosimilar Trends of 2017
On Demand
 Learn more |
Machine learning technology is finding its way into today's clinical trials, as developers look for ways to leverage more qualified data to help diminish patient risk and enhance quality, writes Adam Ross Miller.
| advertisment
Future-proofing your Pharmacovigilance Delivery Model: Achieving scalability and cost effectiveness with AI/smart machines
On Demand
 Learn more |
|
|
Oncology
CRF Health's TrialMax Touch® platform has been selected for a landmark global oncology trial. The study will involve more than 1,000 patients across 200 sites in 20 countries, with CRF's tool collecting electronic clinical outcome assessment (eCOA) data.
|
|
New strategies in clinical trial design to keep pace with the acceleration of cancer drug approvals in recent years.
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
